794 related articles for article (PubMed ID: 12631361)
1. Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.
Rosenstock JL; Markowitz GS; Valeri AM; Sacchi G; Appel GB; D'Agati VD
Kidney Int; 2003 Apr; 63(4):1450-61. PubMed ID: 12631361
[TBL] [Abstract][Full Text] [Related]
2. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis.
Nasr SH; Markowitz GS; Stokes MB; Seshan SV; Valderrama E; Appel GB; Aucouturier P; D'Agati VD
Kidney Int; 2004 Jan; 65(1):85-96. PubMed ID: 14675039
[TBL] [Abstract][Full Text] [Related]
3. Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.
Bridoux F; Hugue V; Coldefy O; Goujon JM; Bauwens M; Sechet A; Preud'Homme JL; Touchard G
Kidney Int; 2002 Nov; 62(5):1764-75. PubMed ID: 12371978
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis.
Grove P; Neale PH; Peck M; Schiller B; Haas M
Mod Pathol; 1998 Jan; 11(1):103-9. PubMed ID: 9556416
[TBL] [Abstract][Full Text] [Related]
5. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases.
Said SM; Rocha AB; Royal V; Valeri AM; Larsen CP; Theis JD; Vrana JA; McPhail ED; Bandi L; Safabakhsh S; Barnes C; Cornell LD; Fidler ME; Alexander MP; Leung N; Nasr SH
Am J Kidney Dis; 2021 Mar; 77(3):454-458. PubMed ID: 32711071
[TBL] [Abstract][Full Text] [Related]
7. Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.
Fogo A; Qureshi N; Horn RG
Am J Kidney Dis; 1993 Sep; 22(3):367-77. PubMed ID: 8372831
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.
Liang S; Chen D; Liang D; Xu F; Zhang M; Yang F; Zhu X; Li P; Zeng C
J Nephrol; 2021 Jun; 34(3):883-892. PubMed ID: 32557205
[TBL] [Abstract][Full Text] [Related]
9. When noncongophilic glomerular fibrils do not represent fibrillary glomerulonephritis: nonspecific mesangial fibrils in sclerosing glomeruli.
Kronz JD; Neu AM; Nadasdy T
Clin Nephrol; 1998 Oct; 50(4):218-23. PubMed ID: 9799066
[TBL] [Abstract][Full Text] [Related]
10. Proliferative glomerulonephritis with monoclonal IgG deposits.
Nasr SH; Satoskar A; Markowitz GS; Valeri AM; Appel GB; Stokes MB; Nadasdy T; D'Agati VD
J Am Soc Nephrol; 2009 Sep; 20(9):2055-64. PubMed ID: 19470674
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course.
Venkataseshan VS; Lieberman K; Kim DU; Thung SN; Dikman S; D'Agati V; Susin M; Valderrama E; Gauthier B; Prakash A
Medicine (Baltimore); 1990 Jul; 69(4):200-16. PubMed ID: 2142748
[TBL] [Abstract][Full Text] [Related]
12. Fibrillary noncongophilic renal and extrarenal deposits: a report on 10 cases.
Hvala A; Ferluga D; Vizjak A; Koselj-Kajtna M
Ultrastruct Pathol; 2003; 27(5):341-7. PubMed ID: 14708725
[TBL] [Abstract][Full Text] [Related]
13. De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograft.
Tsuji T; Miura M; Yanai M; Itami H; Ishii Y; Akimoto M; Fukasawa Y
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():44-7. PubMed ID: 26976360
[TBL] [Abstract][Full Text] [Related]
14. Immunotactoid glomerulopathy.
Korbet SM; Schwartz MM; Rosenberg BF; Sibley RK; Lewis EJ
Medicine (Baltimore); 1985 Jul; 64(4):228-43. PubMed ID: 4010500
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of kidney transplantation in patients with fibrillary glomerulonephritis or monoclonal gammopathy with fibrillary deposits.
Czarnecki PG; Lager DJ; Leung N; Dispenzieri A; Cosio FG; Fervenza FC
Kidney Int; 2009 Feb; 75(4):420-7. PubMed ID: 19037251
[TBL] [Abstract][Full Text] [Related]
16. IgG Subclass Staining in Routine Renal Biopsy Material.
Hemminger J; Nadasdy G; Satoskar A; Brodsky SV; Nadasdy T
Am J Surg Pathol; 2016 May; 40(5):617-26. PubMed ID: 26848798
[TBL] [Abstract][Full Text] [Related]
17. Fibrillary glomerulonephritis: a report of 66 cases from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; Leung N; Fervenza FC
Clin J Am Soc Nephrol; 2011 Apr; 6(4):775-84. PubMed ID: 21441134
[TBL] [Abstract][Full Text] [Related]
18. Immunotactoid glomerulopathy: clinicopathologic and proteomic study.
Nasr SH; Fidler ME; Cornell LD; Leung N; Cosio FG; Sheikh SS; Amir AA; Vrana JA; Theis JD; Dogan A; Sethi S
Nephrol Dial Transplant; 2012 Nov; 27(11):4137-46. PubMed ID: 22872726
[TBL] [Abstract][Full Text] [Related]
19. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
